NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 21.42 Million USD | -13.15% |
| 2022 | 24.66 Million USD | -0.88% |
| 2021 | 24.88 Million USD | 211.31% |
| 2020 | 7.99 Million USD | 15.97% |
| 2019 | 6.89 Million USD | -43.09% |
| 2018 | 12.11 Million USD | 26.19% |
| 2017 | 9.59 Million USD | 15.88% |
| 2016 | 8.28 Million USD | -48.34% |
| 2015 | 16.03 Million USD | 40.63% |
| 2014 | 11.4 Million USD | 5.61% |
| 2013 | 10.79 Million USD | -0.74% |
| 2012 | 10.87 Million USD | -23.51% |
| 2011 | 14.22 Million USD | -38.35% |
| 2010 | 23.06 Million USD | -43.14% |
| 2009 | 40.56 Million USD | 29.28% |
| 2008 | 31.37 Million USD | -44.34% |
| 2007 | 56.37 Million USD | 1.2% |
| 2006 | 55.7 Million USD | 29.86% |
| 2005 | 42.89 Million USD | 13.03% |
| 2004 | 37.95 Million USD | 425.82% |
| 2003 | 7.21 Million USD | 2.34% |
| 2002 | 7.05 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 18.92 Million USD | -8.39% |
| 2024 Q3 | 17.18 Million USD | -9.2% |
| 2024 Q1 | 20.66 Million USD | -3.55% |
| 2023 Q1 | 23.61 Million USD | -4.3% |
| 2023 FY | 21.42 Million USD | -13.15% |
| 2023 Q4 | 21.42 Million USD | 0.65% |
| 2023 Q3 | 21.28 Million USD | -6.53% |
| 2023 Q2 | 22.77 Million USD | -3.54% |
| 2022 FY | 24.66 Million USD | -0.88% |
| 2022 Q1 | 26.24 Million USD | 5.47% |
| 2022 Q2 | 25.25 Million USD | -3.78% |
| 2022 Q3 | 24.03 Million USD | -4.85% |
| 2022 Q4 | 24.66 Million USD | 2.65% |
| 2021 FY | 24.88 Million USD | 211.31% |
| 2021 Q4 | 24.88 Million USD | -5.35% |
| 2021 Q1 | 7.72 Million USD | -3.42% |
| 2021 Q2 | 10.76 Million USD | 39.48% |
| 2021 Q3 | 26.29 Million USD | 144.16% |
| 2020 Q2 | 8.6 Million USD | 38.65% |
| 2020 Q1 | 6.2 Million USD | -9.97% |
| 2020 Q3 | 8.34 Million USD | -3.09% |
| 2020 Q4 | 7.99 Million USD | -4.14% |
| 2020 FY | 7.99 Million USD | 15.97% |
| 2019 Q4 | 6.89 Million USD | -18.96% |
| 2019 Q2 | 10.81 Million USD | -22.24% |
| 2019 Q1 | 13.9 Million USD | 14.81% |
| 2019 FY | 6.89 Million USD | -43.09% |
| 2019 Q3 | 8.5 Million USD | -21.34% |
| 2018 FY | 12.11 Million USD | 26.19% |
| 2018 Q2 | 11.8 Million USD | 14.55% |
| 2018 Q1 | 10.3 Million USD | 7.39% |
| 2018 Q4 | 12.11 Million USD | -7.1% |
| 2018 Q3 | 13.03 Million USD | 10.42% |
| 2017 FY | 9.59 Million USD | 15.88% |
| 2017 Q4 | 9.59 Million USD | 9.42% |
| 2017 Q3 | 8.77 Million USD | 4.65% |
| 2017 Q2 | 8.38 Million USD | -24.41% |
| 2017 Q1 | 11.08 Million USD | 33.87% |
| 2016 Q4 | 8.28 Million USD | -27.01% |
| 2016 Q1 | 12.3 Million USD | -23.24% |
| 2016 Q2 | 14.57 Million USD | 18.44% |
| 2016 FY | 8.28 Million USD | -48.34% |
| 2016 Q3 | 11.34 Million USD | -22.15% |
| 2015 Q2 | 16.03 Million USD | 75.59% |
| 2015 FY | 16.03 Million USD | 40.63% |
| 2015 Q4 | 16.03 Million USD | 24.02% |
| 2015 Q3 | 12.92 Million USD | -19.36% |
| 2015 Q1 | 9.13 Million USD | -19.92% |
| 2014 Q2 | 15.36 Million USD | 62.46% |
| 2014 Q4 | 11.4 Million USD | -15.97% |
| 2014 FY | 11.4 Million USD | 5.61% |
| 2014 Q1 | 9.45 Million USD | -12.42% |
| 2014 Q3 | 13.56 Million USD | -11.67% |
| 2013 Q2 | 11.44 Million USD | 28.76% |
| 2013 Q3 | 9.7 Million USD | -15.25% |
| 2013 Q4 | 10.79 Million USD | 11.27% |
| 2013 FY | 10.79 Million USD | -0.74% |
| 2013 Q1 | 8.89 Million USD | -18.26% |
| 2012 Q2 | 15.68 Million USD | -14.45% |
| 2012 Q3 | 13.19 Million USD | -15.83% |
| 2012 Q4 | 10.87 Million USD | -17.59% |
| 2012 Q1 | 18.33 Million USD | 28.9% |
| 2012 FY | 10.87 Million USD | -23.51% |
| 2011 FY | 14.22 Million USD | -38.35% |
| 2011 Q1 | 20.29 Million USD | -12.01% |
| 2011 Q4 | 14.22 Million USD | -11.94% |
| 2011 Q3 | 16.14 Million USD | -9.07% |
| 2011 Q2 | 17.75 Million USD | -12.5% |
| 2010 FY | 23.06 Million USD | -43.14% |
| 2010 Q3 | 27.98 Million USD | -10.51% |
| 2010 Q4 | 23.06 Million USD | -17.58% |
| 2010 Q2 | 31.27 Million USD | -13.3% |
| 2010 Q1 | 36.06 Million USD | -11.09% |
| 2009 Q1 | 27.4 Million USD | -12.67% |
| 2009 FY | 40.56 Million USD | 29.28% |
| 2009 Q4 | 40.56 Million USD | -5.16% |
| 2009 Q3 | 42.77 Million USD | 62.04% |
| 2009 Q2 | 26.39 Million USD | -3.67% |
| 2008 Q2 | 43.75 Million USD | -11.61% |
| 2008 Q1 | 49.49 Million USD | -12.19% |
| 2008 Q4 | 31.37 Million USD | -13.11% |
| 2008 Q3 | 36.11 Million USD | -17.46% |
| 2008 FY | 31.37 Million USD | -44.34% |
| 2007 Q3 | 50.71 Million USD | -3.71% |
| 2007 Q1 | 54.14 Million USD | -2.81% |
| 2007 FY | 56.37 Million USD | 1.2% |
| 2007 Q4 | 56.37 Million USD | 11.15% |
| 2007 Q2 | 52.67 Million USD | -2.72% |
| 2006 Q1 | 44.58 Million USD | 3.94% |
| 2006 Q2 | 47.7 Million USD | 6.99% |
| 2006 Q3 | 52.59 Million USD | 10.24% |
| 2006 Q4 | 55.7 Million USD | 5.92% |
| 2006 FY | 55.7 Million USD | 29.86% |
| 2005 Q1 | 38.54 Million USD | 1.56% |
| 2005 FY | 42.89 Million USD | 13.03% |
| 2005 Q4 | 42.89 Million USD | 6.49% |
| 2005 Q3 | 40.28 Million USD | 3.19% |
| 2005 Q2 | 39.03 Million USD | 1.28% |
| 2004 Q2 | 18.36 Million USD | 7.54% |
| 2004 Q3 | 38.04 Million USD | 107.13% |
| 2004 FY | 37.95 Million USD | 425.82% |
| 2004 Q4 | 37.95 Million USD | -0.24% |
| 2004 Q1 | 17.07 Million USD | 136.63% |
| 2003 FY | 7.21 Million USD | 2.34% |
| 2003 Q4 | 7.21 Million USD | 0.0% |
| 2002 FY | 7.05 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 31.695% |
| BrainsWay Ltd. | 62.97 Million USD | 65.978% |
| Cerus Corporation | 197.74 Million USD | 89.166% |
| Envoy Medical, Inc. | 7.64 Million USD | -180.425% |
| electroCore, Inc. | 16.38 Million USD | -30.74% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -178.529% |
| IceCure Medical Ltd | 16.41 Million USD | -30.557% |
| Inogen, Inc. | 326.19 Million USD | 93.432% |
| OrthoPediatrics Corp. | 449.58 Million USD | 95.235% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 21.436% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -29.226% |
| MaxCyte, Inc. | 268.27 Million USD | 92.014% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -164.587% |
| Nexalin Technology, Inc. | 3.63 Million USD | -489.894% |
| Orthofix Medical Inc. | 925.31 Million USD | 97.685% |
| PAVmed Inc | 33.11 Million USD | 35.311% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 85.065% |
| RxSight, Inc. | 182.55 Million USD | 88.264% |
| Sight Sciences, Inc. | 166.65 Million USD | 87.144% |
| SI-BONE, Inc. | 230.42 Million USD | 90.702% |
| TELA Bio, Inc. | 78.04 Million USD | 72.55% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 91.495% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -99.669% |
| Acutus Medical, Inc. | 53.96 Million USD | 60.296% |
| Talis Biomedical Corporation | 98.34 Million USD | 78.214% |
| Spectral AI, Inc. | 10.69 Million USD | -100.378% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 90.201% |
| CVRx, Inc. | 115.22 Million USD | 81.407% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 63.478% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -587.727% |
| Bioventus Inc. | 810.91 Million USD | 97.358% |
| Venus Concept Inc. | 93.65 Million USD | 77.124% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 16.717% |
| LivaNova PLC | 2.42 Billion USD | 99.118% |
| 908 Devices Inc. | 202.98 Million USD | 89.445% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 97.339% |
| Nemaura Medical Inc. | 14.56 Million USD | -47.113% |
| NeuroPace, Inc. | 107.65 Million USD | 80.098% |
| LENSAR, Inc. | 69.58 Million USD | 69.211% |
| Apyx Medical Corporation | 79.24 Million USD | 72.963% |
| Cutera, Inc. | 346.29 Million USD | 93.813% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 49.009% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1091.571% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 92.084% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 49.78% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.434% |
| Axonics, Inc. | 719.92 Million USD | 97.024% |
| Outset Medical, Inc. | 313.8 Million USD | 93.173% |
| IRIDEX Corporation | 34.43 Million USD | 37.785% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 94.706% |
| IRadimed Corporation | 92.15 Million USD | 76.752% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -307.774% |
| INVO Bioscience, Inc. | 20.88 Million USD | -2.569% |
| Telesis Bio, Inc. | 70.41 Million USD | 69.572% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 86.097% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.285% |
| Quipt Home Medical Corp. | 247.4 Million USD | 91.34% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -130.123% |
| Pulmonx Corporation | 178.95 Million USD | 88.028% |
| Dynatronics Corporation | 25.94 Million USD | 17.409% |
| Modular Medical, Inc. | 13.8 Million USD | -55.171% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -99.724% |
| Semler Scientific, Inc. | 78.06 Million USD | 72.556% |
| InMode Ltd. | 863.28 Million USD | 97.518% |
| Bruker Corporation | 4.24 Billion USD | 99.496% |
| Cytosorbents Corporation | 53.26 Million USD | 59.774% |
| DexCom, Inc. | 6.26 Billion USD | 99.658% |
| Align Technology, Inc. | 6.08 Billion USD | 99.648% |
| Viveve Medical, Inc. | 25.91 Million USD | 17.322% |
| ZimVie Inc. | 1.2 Billion USD | 98.223% |
| Movano Inc. | 9.42 Million USD | -127.412% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 95.695% |
| Nexalin Technology, Inc. | 3.63 Million USD | -489.894% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 63.478% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 97.751% |
| Profound Medical Corp. | 43.68 Million USD | 50.958% |
| Insulet Corporation | 2.58 Billion USD | 99.172% |
| enVVeno Medical Corporation | 48.63 Million USD | 55.949% |
| Surmodics, Inc. | 185.73 Million USD | 88.465% |
| iCAD, Inc. | 41.41 Million USD | 48.273% |
| Nuwellis, Inc. | 9.77 Million USD | -119.288% |
| Biotricity, Inc. | 5.94 Million USD | -260.522% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 95.054% |
| Aethlon Medical, Inc. | 8.24 Million USD | -159.817% |
| InspireMD, Inc. | 47.64 Million USD | 55.031% |
| PAVmed Inc. | 33.11 Million USD | 35.311% |
| BIOLASE, Inc. | 35.1 Million USD | 38.963% |
| Beyond Air, Inc. | 56.96 Million USD | 62.388% |
| FONAR Corporation | 214.24 Million USD | 90.0% |
| AxoGen, Inc. | 196.82 Million USD | 89.115% |
| Vivani Medical, Inc. | 45.79 Million USD | 53.219% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 92.388% |
| Inari Medical, Inc. | 674.23 Million USD | 96.822% |
| UFP Technologies, Inc. | 404.13 Million USD | 94.699% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 8.437% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -125.447% |
| Tenon Medical, Inc. | 6.34 Million USD | -237.659% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -127.75% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 79.33% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.536% |
| Sintx Technologies, Inc. | 15.36 Million USD | -39.437% |
| NanoVibronix, Inc. | 6.67 Million USD | -221.014% |
| Quanterix Corporation | 425.01 Million USD | 94.959% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -130.123% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 60.124% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.773% |
| TransMedics Group, Inc. | 706.04 Million USD | 96.966% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 66.096% |
| Hyperfine, Inc. | 94.19 Million USD | 77.256% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 92.025% |
| Biomerica, Inc. | 9.25 Million USD | -131.515% |
| Bone Biologics Corporation | 3.73 Million USD | -473.189% |
| AVITA Medical, Inc. | 144.33 Million USD | 85.157% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -340.06% |
| Silk Road Medical, Inc | 265.3 Million USD | 91.925% |